HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
COVID Breathalyzer, Distinguished Career Awardee, Kids’ COVID Vaccine, Youth-Onset Type 2 Diabetes, Mental Health and Greenspace
Related Departments
1 - 10 of 11
Leading pediatric research and care with innovative basic laboratory, translational, and clinical research programs spanning all pediatric divisions and subspecialties.
Leading the way in understanding the delicate balance between the genetic, epigenetic, and environmental impacts on the development of endocrine disease.
Using state-of-the-art data sources, techniques and tools, the research programs within the Division of Infectious Diseases seek to define the mechanisms and outcomes of a wide array of infectious microbes and disease processes.
Advancing state-of-the-art cancer investigation and care for children through a world-renowned, integrated basic, translational, and clinical research environment.
Improving cure rates and decreasing side effects for children, adolescents, and young adults.
The Center for Human Phenomic Science provides the resources, environment, operations, and training to support and promote high-quality clinical and translational research by qualified investigators.
Using clinical effectiveness research to discover and disseminate knowledge about best practices in the management of pediatric disease.
LiBI conducts research in children, adolescents, and adults to study how brain and behavior change over time and in response to illness, with a focus on risk and resilience factors. Areas of research include behavior, cognition, environmental risk, genetics, neuroimaging, and animal models.
Children’s Hospital of Philadelphia has partnered with Vanderbilt University Medical Center as a subsidiary of the Vaccine and Treatment Evaluation Unit (VTEU). NIAID established the VTEUs in 1962 as a ready resource for conducting clinical trials of vaccines and treatments for infectious diseases.
Research in the Brodeur Lab focuses on two main areas: nanoparticle drug delivery and cancer predisposition. Nanomedicines allow the delivery of much more drug to the tumor and much less to the patient. The lab is also interested in identifying novel cancer predisposition genes as well as developing enhanced surveillance techniques to identify cancer early in predisposed individuals, improve outcomes, and reduce side effects.